BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Pharmacogenetics, Fluoxetine, rs4950928, ERBB2, T cell receptor signaling pathway)
Bookmark Forward

QuickView for Beclin-1 (gene)


Body Atlas

Most Correlated Tissues

  1. Eosinophil of peripheral blood
  2. Colon mucosa
  3. Basophil of peripheral blood
  4. Microglial cell
  5. Monocyte of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Disorder of intraocular pressure
  2. Perforation of tympanic membrane
  3. Cholestasis
  4. Stricture of artery
  5. Hepatocellular dysplasia
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. dibenz(a,h)anthracene-1,2,3,4-tetrahydro-3,4-diol
  2. mycophenolate mofetil
  3. Minocycline
  4. Todralazine
  5. fipexide
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. PTGES
  2. PPP1R8
  3. CSH2
  4. BCL3
  5. ZNF669
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. BECLIN1: Protein Structure, Function and Regulation.
  2. In vivo evidence for therapeutic applications of beclin 1 to promote recovery and inhibit fibrosis a…
  3. Therapeutic potential of Beclin1 for transition from AKI to CKD: autophagy-dependent and autophagy-i…
  4. Downregulation of beclin 1 restores arsenite-induced impaired autophagic flux by improving the lysos…
  5. The secretory function of BECN1 in metabolic regulation.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Expression of LC3-I, LC3-II & Beclin 1 in Vitiligo
  2. Autophagy Markers in Endometrial Polyps
  3. Low Protein Diet in Patients With Collagen VI Related Myopathies
  4. Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Acti…
  5. Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Seconda…
Explore Clinical Trials Results
  • Copyright © 2023 Illumina Inc. All rights reserved.